# L_2020344EN.01001801.xml

| 19.10.2020 | EN | Official Journal of the European Union | L 344/18 |
| --- | --- | --- | --- |

19.10.2020

EN

Official Journal of the European Union

L 344/18

---

COMMISSION IMPLEMENTING REGULATION (EU) 2020/1511

of 16 October 2020

amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular the first paragraph of Article 17 thereof,

Whereas:

| (1) | Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009. |
| --- | --- |

(1)

Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.

| (2) | Commission Implementing Regulation (EU) 2019/1589 (3) extended the approval periods of the active substances chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, indoxacarb, MCPA, MCPB and prosulfocarb until 31 October 2020. |
| --- | --- |

(2)

Commission Implementing Regulation (EU) 2019/1589 (3) extended the approval periods of the active substances chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, indoxacarb, MCPA, MCPB and prosulfocarb until 31 October 2020.

| (3) | Implementing Regulation (EU) 2019/1589 extended the approval period of the active substance tritosulfuron until 30 November 2020. |
| --- | --- |

(3)

Implementing Regulation (EU) 2019/1589 extended the approval period of the active substance tritosulfuron until 30 November 2020.

| (4) | Implementing Regulation (EU) 2019/1589 extended the approval periods of the active substances amidosulfuron, bifenox, clofentezine, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, lenacil, nicosulfuron, picloram and triflusulfuron until 31 December 2020. |
| --- | --- |

(4)

Implementing Regulation (EU) 2019/1589 extended the approval periods of the active substances amidosulfuron, bifenox, clofentezine, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, lenacil, nicosulfuron, picloram and triflusulfuron until 31 December 2020.

| (5) | Commission Implementing Regulation (EU) 2017/555 (4) extended the approval periods of the active substances paraffin oils and sulphur until 31 December 2020. |
| --- | --- |

(5)

Commission Implementing Regulation (EU) 2017/555 (4) extended the approval periods of the active substances paraffin oils and sulphur until 31 December 2020.

| (6) | Applications for the renewal of the approval of those substances were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 (5). |
| --- | --- |

(6)

Applications for the renewal of the approval of those substances were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 (5).

| (7) | Due to the fact that the assessment of those substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision is taken on their renewal. It is therefore necessary to extend their approval periods by one year. |
| --- | --- |

(7)

Due to the fact that the assessment of those substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision is taken on their renewal. It is therefore necessary to extend their approval periods by one year.

| (8) | As regards cases where a Regulation on the non-renewal of the approval of the active substances concerned is to be adopted because the approval criteria are not satisfied, the expiry date is either to be reset to the date applicable before the adoption of this Regulation or is to coincide with the date of entry into force of the Regulation on the non-renewal, whichever date is later. As regards cases where a Regulation on the renewal of the approval of the active substances concerned is to be adopted, the earliest possible application date is to be set, as the circumstances allow. |
| --- | --- |

(8)

As regards cases where a Regulation on the non-renewal of the approval of the active substances concerned is to be adopted because the approval criteria are not satisfied, the expiry date is either to be reset to the date applicable before the adoption of this Regulation or is to coincide with the date of entry into force of the Regulation on the non-renewal, whichever date is later. As regards cases where a Regulation on the renewal of the approval of the active substances concerned is to be adopted, the earliest possible application date is to be set, as the circumstances allow.

| (9) | Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly. |
| --- | --- |

(9)

Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

| (10) | Taking into account the fact that the approvals of some of the substances expire on 31 October 2020, this Regulation should enter into force as soon as possible. |
| --- | --- |

(10)

Taking into account the fact that the approvals of some of the substances expire on 31 October 2020, this Regulation should enter into force as soon as possible.

| (11) | The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, |
| --- | --- |

(11)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 16 October 2020.

For the Commission

The President

Ursula VON DER LEYEN

---

(1)  
  OJ L 309, 24.11.2009, p. 1.

1

(2)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

2

(3)  Commission Implementing Regulation (EU) 2019/1589 of 26 September 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (OJ L 248, 27.9.2019, p. 24).

3

(4)  Commission Implementing Regulation (EU) 2017/555 of 24 March 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of several active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 (AIR IV renewal programme) (OJ L 80, 25.3.2017, p. 1).

4

(5)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).

5

---

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

| (1) | in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(1)

in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2021’;

| (2) | in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(2)

in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2021’;

| (3) | in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(3)

in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2021’;

| (4) | in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(4)

in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2021’;

| (5) | in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(5)

in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2021’;

| (6) | in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(6)

in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2021’;

| (7) | in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(7)

in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2021’;

| (8) | in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(8)

in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2021’;

| (9) | in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(9)

in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2021’;

| (10) | in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(10)

in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2021’;

| (11) | in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(11)

in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2021’;

| (12) | in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2021’; |
| --- | --- |

(12)

in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2021’;

| (13) | in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(13)

in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2021’;

| (14) | in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(14)

in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2021’;

| (15) | in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(15)

in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2021’;

| (16) | in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(16)

in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2021’;

| (17) | in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(17)

in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2021’;

| (18) | in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(18)

in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2021’;

| (19) | in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(19)

in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2021’;

| (20) | in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(20)

in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2021’;

| (21) | in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(21)

in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2021’;

| (22) | in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(22)

in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2021’;

| (23) | in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(23)

in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2021’;

| (24) | in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2021’; |
| --- | --- |

(24)

in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2021’;

| (25) | in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(25)

in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2021’;

| (26) | in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2021’; |
| --- | --- |

(26)

in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2021’;

| (27) | in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2021’. |
| --- | --- |

(27)

in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2021’.

---